Item 2. PROPERTIES

The Company's corporate headquarters are located in Wilmington, Delaware. The Company's manufacturing, processing, marketing and research and development facilities, as well as regional purchasing offices and distribution centers are located throughout the world. Additional information with respect to the Company's property, plant and equipment and leases is contained in Notes 12, 17 and 24 to the Consolidated Financial Statements.

The Company has investments in property, plant and equipment related to global manufacturing operations. Collectively there are approximately 195 principal sites in total. The number of manufacturing sites by reportable segment and geographic area around the world at December 31, 2019 is as follows:



Geographic Region	Elect. & Imaging	Nutrition & Biosciences	Transp. & Industrial	Safety & Const.	Non-Core	Total 2
Asia Pacific	17	15	15	11	3	61
EMEA 1	4	41	8	6	1	60
Latin America	—	13	2	—	—	15
U.S. & Canada	12	21	20	13	7	73
Total	33	90	45	30	11	209

1.. Europe, Middle East, and Africa ("EMEA").


2.	Sites that are used by multiple segments are included more than once in the figures above.

The Company's principal sites include facilities which, in the opinion of management, are suitable and adequate for their use and have sufficient capacity for the Company's current needs and expected near-term growth. Properties are primarily owned by the Company; however, certain properties are leased. No title examination of the properties has been made for the purpose of this report and certain properties are shared with other tenants under long-term leases.

Previous: Item 1B. UNRESOLVED STAFF COMMENTS. · Next: Item 3. LEGAL PROCEEDINGS